EP Patent

EP2475392A1 — Methods for treating irritable bowel syndrome (ibs)

Assigned to Salix Pharmaceuticals Ltd · Expires 2012-07-18 · 14y expired

What this patent protects

The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.

USPTO Abstract

The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.

Drugs covered by this patent

Patent Metadata

Patent number
EP2475392A1
Jurisdiction
EP
Classification
—
Expires
2012-07-18
Drug substance claim
No
Drug product claim
No
Assignee
Salix Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.